Indatraline
| Lu 19-005 | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 292.2 g/mol [1] |
| Predicted LogP | 4.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H15Cl2N [1] |
| IUPAC name | (1R,3S)-3-(3,4-dichlorophenyl)-N-methyl-2,3-dihydro-1H-inden-1-amine [1] |
| SMILES | CN[C@@H]1C[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl [1] |
| InChI | InChI=1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1 [1] |
| InChIKey | SVFXPTLYMIXFRX-XJKSGUPXSA-N [1] |
Indatraline (also known as Indatralinum, Dtxsid4043981, trans-3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine, indatralina, Dtxcid2023981, Chembl341898, trans-3-(3,4-dichlorophenyl)-N-methyl-1-indanamine, Unii-4u40y96j1z, Lu-19-005 or Lopac-I-119) is a
Chemistry
Stereochemistry []
Indatraline is a achiral mixture of the optical stereoisomers.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 126280, Indatraline. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/126280
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Indatraline. UNII: 4U40Y96J1Z. Global Substance Registration System. Accessed May 8, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4U40Y96J1Z